Outlook Therapeutics
OTLK
OTLK
53 hedge funds and large institutions have $4.29M invested in Outlook Therapeutics in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 24 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
55% less capital invested
Capital invested by funds: $9.5M → $4.29M (-$5.22M)
61% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 18
Holders
53
Holding in Top 10
–
Calls
$351K
Puts
$89K
Top Buyers
| 1 | +$99.3K | |
| 2 | +$96.5K | |
| 3 | +$94K | |
| 4 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$90.1K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$87.6K |
Top Sellers
| 1 | -$689K | |
| 2 | -$450K | |
| 3 | -$392K | |
| 4 |
Squarepoint
New York
|
-$249K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$180K |
